"Unraveling the Mystery: The Fate of the Project to Break the Wealthy World's Monopoly on mRNA Vaccines"
Afrigen Biologics and Vaccines, a South African pharmaceutical firm, is making progress in its efforts to develop mRNA vaccines against COVID-19 and other diseases, with the goal of expanding global access to vaccines. The company has successfully reverse-engineered the process of making mRNA vaccines and has demonstrated that its version is comparable to Moderna's. Afrigen is also training scientists from 15 countries on mRNA vaccine production and has plans to share its knowledge and expertise. However, the company has faced delays due to the emergence of new variants and is now working on validating its current vaccine in primates and developing a new mRNA vaccine tailored to the more recent strains.